Prevalence of Arthritis Underestimated in United States

This article originally appeared here.
Share this content:
Prevalence of Arthritis Underestimated in United States
Prevalence of Arthritis Underestimated in United States

TUESDAY, Nov. 28, 2017 (HealthDay News) -- The prevalence of arthritis in the United States seems to have been underestimated, with 91.2 million adults affected in 2015, according to a study published online Nov. 27 in Arthritis & Rheumatology.

S. Reza Jafarzadeh, D.V.M., Ph.D., and David T. Felson, M.D., M.P.H., from the Boston University School of Medicine, used the 2015 National Health Interview Survey data to estimate arthritis prevalence based on an expansive surveillance definition. The model for arthritis surveillance was based on doctor-diagnosed arthritis, joint symptoms, and symptom duration exceeding three months. Data were included for 33,672 participants.

The researchers found that 19.3 percent of men and 16.7 percent of women aged 18 to 64 years affirmed joint symptoms without doctor-diagnosed arthritis; for those aged ≥65 years, the proportions were 15.7 and 13.5 percent, respectively. The measurement error-adjusted prevalence of arthritis was 29.9 and 31.2 percent, respectively, for men and women aged 18 to 64 years, and 55.8 and 68.7 percent, respectively, for men and women aged ≥65 years. In 2015, arthritis affected 91.2 million adults in the United States, including 61.1 million aged 18 to 64 years. These estimates are 68 percent higher than those reported previously.

"Arthritis prevalence in the U.S. population has been substantially underestimated, especially among adults <65 years," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »